Obstructive Sleep Apnea (OSA)NCT07688603
Level 3 Validation Study
A study testing Comparison 1: Level 1 Polysomnography: Cadwell/Alice and Comparison 2: Level 3 Test: Berry Sleep Apnea Screening Monitor in people with Obstructive Sleep Apnea (OSA), run by Windsor Sleep Disorders Clinic.
Trial summary
This study will compare the output of a new Level 3 polysomnography system against in-laboratory polysomnography. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Obstructive Sleep Apnea (OSA)
- What is being tested?
- Comparison 1: Level 1 Polysomnography: Cadwell/Alice and Comparison 2: Level 3 Test: Berry Sleep Apnea Screening Monitor
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 80 participants
- Where
- No sites listed yet
- Study dates
- Jun 2026to Nov 2026
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Referred for a diagnostic sleep study
Who cannot join
- under the age of 18
- significant cardiopulmonary disease, neuromuscular disease or stroke
- other significant sleep disorders
- use of opiate medications
About this study
Official title: Comparison of Home Level 3 Polysomnography to In-Laboratory Polysomnography
This study will compare the output of a new Level 3 polysomnography system against in-laboratory polysomnography.
- Conditions
- Obstructive Sleep Apnea (OSA)
- Being tested
- Comparison 1: Level 1 Polysomnography: Cadwell/Alice, Comparison 2: Level 3 Test: Berry Sleep Apnea Screening Monitor
- Medical subject headings
- Sleep Apnea, Obstructive
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Comparison 1: Level 1 Polysomnography: Cadwell/AliceDevice
Also called Cadwell, Alice
Gold standard measurement of sleep to compare against.
Comparison 2: Level 3 Test: Berry Sleep Apnea Screening MonitorDevice
Also called Berry Sleep Apnea Screening Monitor
Novel Level 3 test under development.
| Study group | Role | What they receive |
|---|---|---|
| Sleep Laboratory Patients | Experimental | Not described Receives: Device: Comparison 1: Level 1 Polysomnography: Cadwell/Alice; Device: Comparison 2: Level 3 Test: Berry Sleep Apnea Screening Monitor |
What is being measured
The primary outcome is the main question the study is designed to answer.
Apneas
Frequency of apneas (events per hour)
Measured: 1 night recording per test
Oxygen Saturation
Oxygen saturation (%)
Measured: 1 Night recording per test
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Jul 2026
- Study startJun 2026 (estimated)
- Primary completionNov 2026 (estimated)
- Study completionNov 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Obstructive Sleep Apnea (OSA)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 80 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Windsor Sleep Disorders Clinic
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07688603
- Sponsor's protocol ID
- Level3Validation
- Status last verified
- Jul 2026
- First submitted
- 9 Apr 2026
- Last updated
- 7 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No